BioStrand (a subsidiary of IPA)’s Post

High throughput in silico mAb #EpitopeBinning with proven wet lab validation   Our case study proves LENSᵃⁱ™ in silico epitope binning delivers near-perfect agreement with wet lab binning.    Key Benefits: - Proven: Matches wet lab binning methods with high accuracy. - Scalable for High-Throughput Analysis: Results within hours for small subsets to 2 weeks for >5k #antibodies. - Fast and Efficient: Designed to reduce time and costs   Read the full case study. https://lnkd.in/efWW6K9e #InSilico #mAb #DrugDisccovery

To view or add a comment, sign in

Explore topics